Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial dysfunction in neurodegenerative diseases

M F Beal1

  • 1Neurology Service/WRN 408, Massachusetts General Hospital and Harvard Medical School, 32 Fruit Street, Boston, MA 02114, USA. beal@helix.harvard.mgh.edu

Biochimica Et Biophysica Acta
|August 26, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy.

Cell death and differentiation·2015
Same author

Impaired brain creatine kinase activity in Huntington's disease.

Neuro-degenerative diseases·2010
Same author

Influence of mitochondrial enzyme deficiency on adult neurogenesis in mouse models of neurodegenerative diseases.

Neuroscience·2008
Same author

Neuroprotective and neurorestorative strategies for neuronal injury.

Neurotoxicity research·2006
Same author

Prospects for redox-based therapy in neurodegenerative diseases.

Neurotoxicity research·2006
Same author

Retraction.

Proceedings of the National Academy of Sciences of the United States of America·2006

Mitochondrial dysfunction is increasingly recognized as a common pathway in neurodegenerative diseases like Alzheimer's and Parkinson's. Therapeutic strategies focus on managing cellular energy and reducing oxidative stress.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Mitochondrial dysfunction is a potential unifying factor in diverse neurodegenerative diseases.
  • It leads to impaired calcium buffering, free radical generation, and excitotoxicity.

Purpose of the Study:

  • To explore the role of mitochondrial dysfunction as a final common pathway in neurodegenerative diseases.
  • To review the molecular mechanisms and genetic links in diseases like Alzheimer's, Friedreich's ataxia, ALS, and Huntington's disease.

Main Methods:

  • Review of recent studies on cybrid cell lines for Alzheimer's disease.
  • Analysis of genetic mutations (GAA repeat, SOD1, CAG repeat) in Friedreich's ataxia, ALS, and Huntington's disease.
  • Examination of bioenergetic defects in Huntington's disease models.

Related Experiment Videos

Main Results:

  • Sporadic Alzheimer's disease linked to cytochrome oxidase deficiency.
  • Friedreich's ataxia involves mitochondrial iron overload and oxidative damage due to frataxin dysfunction.
  • Familial ALS associated with mutations in superoxide dismutase, potentially increasing free radicals.
  • Huntington's disease shows evidence of bioenergetic deficits.

Conclusions:

  • Mitochondrial dysfunction is a shared mechanism in various neurodegenerative conditions.
  • Oxidative damage is a significant consequence.
  • Therapeutic avenues include ATP buffering and free radical scavenging.